Can a Cheek Swab Be Used to Diagnose Alzheimer’s? 3D Clinical Trial Suggests it Can

Can a Cheek Swab Be Used to Diagnose Alzheimer’s? 3D Clinical Trial Suggests it Can
Canada’s 3D Signatures has developed a simple cheek swab to identify patients with Alzheimer’s disease (AD), and even distinguish among those with mild, moderate or severe stages of the illness, according to results from a clinical trial. The analyses, based on the company’s TeloView software platform, will appear in the Journal of Alzheimer’s Disease, though a 3D press release did not specify when. The search for sensitive

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *